Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001011438-00-000117
Filing Date
2000-02-11
Accepted
2000-02-11 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 10622
  Complete submission text file 0001011438-00-000117.txt   12685
Mailing Address 10105 E VIA LINDA 103 382 SCOTTSDALE AZ 85258
Business Address 10105 E VIA LINDA 103 382 SCOTTSDALE AZ 85258 6026142874
MEDITECH PHARMACEUTICALS INC (Subject) CIK: 0000717588 (see all company filings)

EIN.: 953819300 | State of Incorp.: NV | Fiscal Year End: 0531
Type: SC 13G | Act: 34 | File No.: 005-36623 | Film No.: 536012
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3650 WESBROOK MALL VANCOUVER BC CANADA V6S 2L2 VANCOUVER BC A1
Business Address 3650 WESBROOK MALL VANCOUVER BRITISH COLUMBIA CANADA V6S 2L2 A1 00000 6042225541
IMMUNE NETWORK RESEARCH LTD (Filed by) CIK: 0001097907 (see all company filings)

EIN.: 891078933 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research